1Tanaka S, Kobayashi T, Nakanishi K, et al. Association of HLA-DQ genotype in autoantibody-negative and rapid-onset type 1 diabetes. Diabetes Care, 2002, 25: 2302-2307.
2Nakamura T, Nagasaka S, Kusaka l, et al. HLA-DR-DQ baplotype in rapid-onset type 1 diabetes in Japanese. Diabetes Care, 2003, 26: 1640-1641.
3Taniguchi T, Okazaki K, Okamoto M, et al Autoantibodies against the exocrine pancreas in fulminant type 1 diabetes. Pancreas, 2005, 30: 191-192.
4Nagata M, Moriyama H, Kotani R, et al. Immunological aspects of fulminant type 1 diabetes '. Diabetes Res Clin Pract, 2007, 77(Suppl 1): S99-S103.
5Shimizu I, Makino H, Imagawa A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab, 2006, 91: 471-476.
6Sekine N, Motokura T, Oki T, et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbarnazepine hypersensitivity syndrome. JAMA, 2001, 285: 1153-1154.
7Sano H, Terasaki J, Tsutsumi C, et al. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res Clin Pract, 2008, 79: e8-e9.
9Iwaoka T. A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies. Endocr J, 2003, 50: 225-231.
10Iyoda M, Kuroki A, Kato K, et al. A case of acute renal failure due to rhabdomyolysis, associated with nonautoimmune fulminant type 1B diabetes mellitus. Clin Nephrol, 2003, 59: 301-304.
3Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies, Osaka IDDM Study Group. N Engl J Med, 2000, 342: 301-307.
4Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes : a nationwide survey in Japan. Diabetes Care, 2003,26 : 2345-2352.
5Murase Y, Imagawa A, Hanafusa T, et al. Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy-a nationwide 5-year-study in Japan. Diabetologia, 2007, 50: 531- 537.
6Iyoda M, Kuroki A, Kato K, et al. A case of acute renal failure due to rhabdomyolysis, associated with non-autoimmune fulminant type 1B diabetes mellitus. Clin Nephrol, 2003, 59:301-304.
7Fujinaga A, Terao Y, Tanabe T, et al. A case of fulminant type 1 diabetes mellitus complicated with acute renal failure treated with continuous hemodiafiltration. Masui, 2007, 56 : 175-177.
8Iwaoka T. A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies. Endocr J, 2003, 50:225-231.
9Joffe HV, Abrahamson MJ. Case study: tea-colored urine in a patient with diabetic ketoacidosis. Clin Diabetes, 2004, 22 : 197- 198.
5Tanaka S, Endo T, Aida K, et al. Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C - pcptidc response and HbA1 c levels at onset. Diabetes Care 2004 ;27:1936 - 1941.
6Takahashi S, Uchino H, Shimizu T, et al. Comparison of glycatexl albumin (GA) and glyeated hemoglobin ( HbA1 c) in type 2 diabetic patients: usefulness of GA for evaluation of short - term changes in glycemic control. Endocr J 2007;54:139 - 144.
7Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine 1982;61: 141- 152.
8Joffe I-IV, Abrahamson MI. Case Study: Tea -Colored Urine in a Patient With Diabetic Ketoacidosis. Clinical Diabetes 2004 ;22: 197- 198.
9Murase Y, lmagawa A, Hanafusa T, et al. Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy - a nation- wide 5 - year - study in Japan. Diabetologia 2007 ;50:531 - 537.
10Imagawa A, Hanafusa T, Miyagawa J, et al. A novel sub- type of type I diabetes mellitus characterized by a rapid onset and an absence of diabetes - related antibodies, Osaka IDDM Study Group. N Engl J Med 2000;342:301 - 307.
